SCHEMBL19082133

SCHEMBL19082133

c1ccc2cc(-c3c4ccccc4c(-c4cc5c6ccccc6sc5c5c4sc4cc6ccccc6cc45)c4ccccc34)ccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.35
MAPT P10636 2/20 0.35
S1PR5 Q9H228 7/20 0.33
S1PR4 O95977 6/20 0.33
PTPN1 P18031 1/20 0.33
TNKS O95271 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
GSTP1 P09211 1/20 0.32
GPR84 Q9NQS5 1/20 0.31
GPR3 P46089 1/20 0.31
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082166 0.95 ALOX5 (0.35) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL19082292 0.94 ALOX5 (0.34) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL17944189 0.94 ALOX5 (0.37) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL19082306 0.92 ALOX5 (0.38) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL19082346 0.91 TNKS (0.36) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL19082384 0.90 ALOX5 (0.39) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL17944615 0.89 ALOX5 (0.37) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL17944216 0.88 ALOX5 (0.36) ALOX5MAPTS1PR5S1PR4PTPN1
SCHEMBL19082241 0.86 TNKS (0.39) ALOX5MAPTPTPN1TNKSTNKS2
SCHEMBL17945505 0.86 TNKS (0.39) ALOX5MAPTS1PR5S1PR4PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885MAPT 1294/4885S1PR5 4728/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885MAPT 1294/4885S1PR5 4728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.